UAB Innovative Pharma Baltics

Innovative Pharma Baltics (IPB) is Lithuania's only phytotherapeutic product manufacturer, founded in 2008 in Vilnius. Produces 29 phytotherapeutic products in its own research laboratory. Highlights include ExoGen, the first nanoliposome spray on the market derived from plant exosomes, scientifically proven to protect respiratory cells against viruses including SARS-CoV-2. Exports to USA, UK, Ireland, Denmark, Georgia, Ukraine, Estonia, Latvia, and Morocco.